PHOTOPROTECTIVE COMPOSITIONS CONTAINING MALASSEZIA-DERIVED COMPOUNDS AND/OR CHEMICAL ANALOGS THEREOF
Compounds, compositions, and methods for modulating skin pigmentation and treating or preventing UV-induced skin damage, erythema, aging of the skin, sunburn, and hyperpigmentation in a subject. Malassezia -derived compounds and/or chemical analogs thereof, compositions that comprise such compounds, and methods of treating by administering the compounds and compositions, including methods of inducing melanocyte apoptosis, and modulating arylhydrocarbon receptor (AhR) activity, melanogenesis, and melanin concentration.
1 . A method of treating or preventing UV-induced skin damage in a subject comprising:
contacting the subject with a composition comprising a compound having the structure of the following formula:
wherein:
X is selected from the group consisting of NR 14 and O;
Y is a covalent bond, CR 5 R 6 , O, or NR 15 ;
R 1 , R 2 , R 3 , R 4 , R 7 , R 5 , R 9 , R 10 , and R 11 are independently selected from the group consisting of hydrogen, halogen, CN, hydroxyl, R 16 , or OR 16 ;
R 13 , R 14 , and R 15 are independently hydrogen or R 16 ;
R 5 and R 6 are independently selected from the group consisting of hydrogen, hydroxyl, OR 6 , R 16 , and C 3-6 cycloalkyl, or R 5 and R 6 combine to form an oxo (═O) group or a C 3-6 cycloalkyl;
R 12 is selected from the group consisting of hydrogen, —COR a , and R 16 ;
each R 16 is independently formyl, C 1-9 alkyl, C 2-9 alkenyl, or C 2-9 alkynyl; and,
R a is selected from the group consisting of hydrogen, hydroxyl, and OR 16 ;
wherein:
if R a is hydrogen, Y is CR 5 R 6 , and R 13 and R 14 are both hydrogen,
at least one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , and R 11 is R 16 ; or,
R 5 is selected from the group consisting of hydroxyl, OR 6 , R 16 , and C 3-6 cycloalkyl, or R 5 and R 6 combine to form an oxo (═O) group or a C 3-6 cycloalkyl;
or a cosmetically or pharmaceutically acceptable salt thereof, and a cosmetically or pharmaceutically acceptable vehicle, diluent, or carrier.
2 . The method of claim 1 , wherein the compound has the following structure:
or a cosmetically acceptable salt thereof.
3 . The method of claim 1 , wherein:
Y is CR 5 R 6 ;
R 5 is hydrogen, and R 6 is hydrogen, C 1-4 alkyl, C 3-6 cycloalkyl, or O—(C 1-4 alkyl); or R 5 and R 6 combine to form an oxo (═O) group.
4 . The method of claim 1 , wherein at least one of R 1 , R 2 , R 3 , R 4 , R 7 , R 8 , R 9 , R 10 , and R 11 is C 1-4 alkyl.
5 . The method of claim 1 , wherein each of R 1 , R 2 , R 3 , R 4 , R 7 , R 8 , R 9 , R 10 , and R 11 is hydrogen.
6 . The method of claim 1 , wherein R 12 is —COR a or C 1-4 hydroxyalkyl; and R a is hydrogen or C 1-4 alkyl.
7 . The method of claim 1 ,
wherein:
X is NH;
Y is CR 5 R 6 ;
each of R 1 , R 3 , R 4 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 13 is hydrogen;
R 2 is hydrogen or C 1-4 alkyl;
R 5 is hydrogen, and R 6 is hydrogen, C 1-4 alkyl, C 3-6 cycloalkyl, or O—(C 1-4 alkyl); or R 5 and R 6 combine to form an oxo (═O) group;
R 12 is —COR 8 or C 1-4 hydroxyalkyl; and
R a is hydrogen or C-4 alkyl.
8 . The method according of claim 1 , wherein the compound is selected from the group consisting of:
or a cosmetically or pharmaceutically acceptable salt thereof.
9 . A method of treating or preventing UV-induced aging of the skin in a subject comprising:
contacting the subject with a composition comprising a compound having the structure of the following formula:
wherein:
X is selected from the group consisting of NR 14 and O;
Y is a covalent bond, CR 5 R 6 , O, or NR 15 ;
R 1 , R 2 , R 3 , R 4 , R 7 , R 8 , R 9 , R 10 , and R 11 are independently selected from the group consisting of hydrogen, halogen, CN, hydroxyl, R 16 , or OR 16 ;
R 13 , R 14 , and R 15 are independently hydrogen or R 16 ;
R 5 and R 6 are independently selected from the group consisting of hydrogen, hydroxyl, OR 16 , R 16 , and C 3-6 cycloalkyl, or R 5 and R 6 combine to form an oxo (═O) group or a C 3-6 cycloalkyl;
R 12 is selected from the group consisting of hydrogen, —COR a , and R 16 ;
each R 16 is independently formyl, C 1-9 alkyl, C 2-9 alkenyl, or C 2-9 alkynyl; and,
R a is selected from the group consisting of hydrogen, hydroxyl, and OR 16 ;
wherein:
if R a is hydrogen, Y is CR 5 R 6 , and R 13 and R 14 are both hydrogen,
at least one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , and R 11 is R 16 ; or,
R 5 is selected from the group consisting of hydroxyl, OR 16 , R 16 , and C 3-6 cycloalkyl, or R 5 and R 6 combine to form an oxo (═O) group or a C 3-6 cycloalkyl;
or a cosmetically or pharmaceutically acceptable salt thereof, and a cosmetically or pharmaceutically acceptable vehicle, diluent, or carrier.
10 . The method of claim 9 , wherein the compound has the following structure:
or a cosmetically acceptable salt thereof.
11 . The method of claim 9 , wherein:
Y is CR 5 R 6 ;
R 5 is hydrogen, and R 6 is hydrogen, C 1-4 alkyl, C 3-6 cycloalkyl, or O—(C 1-4 alkyl); or R 5 and R 6 combine to form an oxo (═O) group.
12 . The method of claim 9 , wherein at least one of R 1 , R 2 , R 3 , R 4 , R 7 , R 8 , R 9 , R 10 , and R 11 is C 1-4 alkyl.
13 . The method of claim 9 , wherein each of R 1 , R 2 , R 3 , R 4 , R 7 , R 8 , R 9 , R 10 , and R 11 is hydrogen.
14 . The method of claim 9 , wherein R 12 is —COR a or C 1-4 hydroxyalkyl; and R a is hydrogen or C 1-4 alkyl.
15 . The method of claim 9 ,
wherein:
X is NH;
Y is CR 5 R 6 ;
each of R 1 , R 3 , R 4 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 13 is hydrogen;
R 2 is hydrogen or C 1-4 alkyl;
R 5 is hydrogen, and R 6 is hydrogen, C 1-4 alkyl, C 3-6 cycloalkyl, or O—(C 1-4 alkyl); or R 5 and R 6 combine to form an oxo (═O) group;
R 12 is —COR a or C 1-4 hydroxyalkyl; and
R a is hydrogen or C 1-4 alkyl.
16 . The method according of claim 9 , wherein the compound is selected from the group consisting of:
or a cosmetically or pharmaceutically acceptable salt thereof.